Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA). Complementarity between SAA and C-reactive protein as markers of inflammation
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
Johnson B.D., Kip K.E., Marroquin O.C., et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 726-732
The first international standard for serum amyloid A protein (SAA): evaluation in an international collaborative study
Poole S., Walker D., Gaines Das R.E., et al. The first international standard for serum amyloid A protein (SAA): evaluation in an international collaborative study. J Immunol Methods 214 (1998) 1-10
Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis
Mayer J.M., Raraty M., Slavin J., et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 89 (2002) 163-171
Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils
Hatanaka E., Furlaneto C.J., Ribeiro F.P., Souza G.M., and Campa A. Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol Lett 91 (2004) 33-37
Development of ELISA on microplate for C-reactive protein and establishment of age-dependent normal reference range
Wu T.-L., Chang C.P.-Y., Chia-Ni, et al. Development of ELISA on microplate for C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta 322 (2002) 163-168
Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes
Caballero A.E. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep 4 (2004) 237-246